A carregar...
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
BACKGROUND: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to re...
Na minha lista:
| Publicado no: | Am J Nephrol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889917/ https://ncbi.nlm.nih.gov/pubmed/31665733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503712 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|